As one prominent example, tumor necrosis factor alpha (TNFa) was found to be highly expressed in JAK2-V617F-mutated MPN cells and to correlate with disease burden in primary patient cells [154]. The gene discussed is JAK2; the disease is myeloproliferative disorder.